Last reviewed · How we verify

NCT03686631: DIS

The Digital Incentive Spirometer (DIS): Improving Adherence to Incentive Spirometry

Completed NA Last updated 24 September 2019
What this trial tests

NA trial testing Smartphone Arm in Post-Op Infection in 60 participants. Completed in 14 August 2019.

Timeline
9 July 2019
Primary endpoint
14 August 2019
14 August 2019

Quick facts

Lead sponsorBeth Israel Deaconess Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment60
Start date9 July 2019
Primary completion14 August 2019
Estimated completion14 August 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Beth Israel Deaconess Medical Center

Who can join

18 and older, any sex, with Post-Op Infection or Adherence, Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the protocol is to assess how incentive spirometer data gathered via a smartphone platform can be utilized to improve participant adherence to prescribed incentive spirometer exercises in the post-operative period. Half of the participants will receive a standard of care incentive spirometer with a passive tracking device while the other half of the participants will receive a smartphone connected device and smartphone with an application that will encourage their use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post-Op Infection

Currently open trials in the same condition.

Other Beth Israel Deaconess Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03686631.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing